Win a 2026 Corvette ZR1 with the ZTK Performance Package!

Win this 2026 Corvette ZR1 with the ZTK Performance Package!
The fastest, most powerful Corvette ever!
The flat-top and -bottom steering wheel makes the unique ZR1 badging the focal point.
The potent carbon-fiber wing, underbody strakes and carbon-fiber dive planes work together to produce the highest downforce of any production Corvette in History.
The ZR1 features a 1064 hp 5.5L, twin-turbocharged DOHC flat-plane crank V8 engine dubbed the LT7.
Select Your Donation Amount
  1. $25
    18 Entries
    +9 Promo
  2. $50
    40 Entries
    +20 Promo
  3. $100
    90 Entries
    +45 Promo
  4. $200
    200 Entries
    +100 Promo
  5. $350
    400 Entries
    +200 Promo
  6. $500
    650 Entries
    +325 Promo
  7. $1,000
    1750 Entries
    +875 Promo
  8. $2,000
    4000 Entries
    +2000 Promo
No donation necessary to enter, see details here

Enter today to win this 2026 Chevrolet Corvette ZR1 with the ZTK Performanace Package!

You've got a chance to win a 2026 Corvette ZR1 in Competition Yellow Tintcoat Metallic with the ZTK Performance Package. The King of the Hill returns with the most powerful V8 ever produced in America from an auto manufacturer with mind-bending specs and an iconic design to challenge the world’s best supercars and it could be yours!

The ZR1’s 5.5L LT7 twin-turbocharged DOHC V8 engine starts with the same architecture as Z06’s LT6, the most powerful naturally aspirated production V8 engine ever and takes it to the next level with twin turbochargers — the first time ever for a factory Corvette.

Corvette ZR1’s 5.5L, twin-turbo DOHC flat-plane crank LT7 engine is the result of engineering prowess and pushing the boundaries of what the engine architecture can do. Thoughtful planning produced the best performance from forced induction, married with the 5.5L flat-plane engine architecture.

"There is an insatiable thirst in the sports car world for the ultimate in performance. And the ZR1 is certainly that in the Corvette lineup. It's at the very top."

Josh Holder, Corvette Chief Engineer

The Corvette ZR1 offers speed on tap like no Corvette before it. Two distinct setups, complete with Magnetic Ride dampers, accomplish this. The standard Corvette ZR1 chassis arrives with a sleeker body with lower drag and a small spoiler with customer-adjustable short and tall wickers. It also includes a standard carbon-fiber front splitter, rocker moldings, side intake with integrated brake cooling, and front underwing with stall gurney deflectors. Michelin Pilot Sport 4S tires wrap 20-inch front, and 21-inch rear wheels. The standard chassis blends the best of on-road comfort and track capability with this setup.

Images shown do not depict the actual vehicle since the vehicle has been allocated but not yet built. Options may vary depending on availability.

No donation necessary to enter, see details here
    Sweepstakes Details
  • Close Date
    Sep 27, 2026
  • Close Time
    11:59 PM EDT
  • Drawing Date
    Oct 3, 2026
  • Drawing Time
    2:00 PM EDT
  • Drawing Location
    Carlisle Fairgrounds, Carlisle, PA

About Chip Miller Amyloidosis Foundation
Chip Miller Amyloidosis Foundation
1000 Bryn Mawr Road
Carlisle, PA 17013
717-243-7855

The Chip Miller Amyloidosis Foundation

We can’t forget Chip Miller’s tremendous personal Corvette collection and creation of the grandest Corvette event anywhere on the planet – Corvettes at Carlisle. Chip and his close friend Bill Miller founded the incredibly successful automotive event production company, Carlisle Events, held at the Carlisle Fairgrounds in Pennsylvania.

In December 2003, Chip was diagnosed with a little-known disease called Amyloidosis. Sadly, due to complications from the disease, the world lost an incredibly special human being on March 25, 2004. Had Chip and his doctors been aware of the symptoms of the disease when they first presented, this legend might still be with us today.

Amyloidoses are rare diseases first described over 200 years ago. The disease manifests itself when amyloid proteins deposit and accumulate in the body’s organs and tissue. This accumulation may happen systemically (throughout the body) or locally (in one tissue).

Each year 3,000 cases of Amyloidosis are diagnosed in the United States. Amyloidosis is generally a disease of middle-aged people and older, although the disease has been seen in individuals in their thirties. Men are more likely to be affected than women by a ratio of about 1.5:1. Other diseases can increase the risk of Amyloidosis and family history of the disease may indicate a hereditary version. 10-15% of people with multiple myeloma develop Amyloidosis. Long-term kidney dialysis may increase the risk of dialysis-associated Amyloidosis.

Visit Our Website